ファソラセタム (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "ファソラセタム" in Japanese language version.

refsWebsite

Global rank Japanese rank

7nih.gov

4^th place

24^th place

5doi.org

2^nd place

6^th place

1springer.com

274^th place

596^th place

1mednet-communities.net

low place

1books.google.com

3^rd place

61^st place

1seekingalpha.com

5,344^th place

low place

1prnewswire.com

406^th place

1,806^th place

books.google.com (Global: 3^rd place; Japanese: 61^st place)

Moskowitz, D. H. (2017) (英語). Finding the Genetic Cause and Therapy for ADHD, Autism and 22q. BookBaby (self published). ISBN 9781483590981

doi.org (Global: 2^nd place; Japanese: 6^th place)

“Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders”. Drugs 70 (3): 287–312. (February 2010). doi:10.2165/11319230-000000000-00000. PMID 20166767.
“Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugs”. Current Pharmaceutical Design 8 (2): 125–138. (2002). doi:10.2174/1381612023396582. PMID 11812254.
“ADHD & Pharmacotherapy: Past, Present and Future: A Review of the Changing Landscape of Drug Therapy for Attention Deficit Hyperactivity Disorder”. Therapeutic Innovation & Regulatory Science 49 (5): 632–642. (September 2015). doi:10.1177/2168479015599811. PMC 4564067. PMID 26366330.
Connolly, J; Glessner, J; Kao, C; Elia, J; Hakonarson, H. “ADHD & Pharmacotherapy: Past, Present and Future: A Review of the Changing Landscape of Drug Therapy for Attention Deficit Hyperactivity Disorder.”. Ther Innov Regul Sci 49 (5): 632-642. doi:10.1177/2168479015599811. PMC 4564067. PMID 26366330.
Malykh, AG; Sadaie, MR (12 February 2010). “Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders.”. Drugs 70 (3): 287-312. doi:10.2165/11319230-000000000-00000. PMID 20166767.

mednet-communities.net (Global: low place; Japanese: low place)

“Recommended INN List 40”. WHO Drug Information 12 (2). (1998).

nih.gov (Global: 4^th place; Japanese: 24^th place)

pubmed.ncbi.nlm.nih.gov

“Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders”. Drugs 70 (3): 287–312. (February 2010). doi:10.2165/11319230-000000000-00000. PMID 20166767.
“Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugs”. Current Pharmaceutical Design 8 (2): 125–138. (2002). doi:10.2174/1381612023396582. PMID 11812254.
“ADHD & Pharmacotherapy: Past, Present and Future: A Review of the Changing Landscape of Drug Therapy for Attention Deficit Hyperactivity Disorder”. Therapeutic Innovation & Regulatory Science 49 (5): 632–642. (September 2015). doi:10.1177/2168479015599811. PMC 4564067. PMID 26366330.
Connolly, J; Glessner, J; Kao, C; Elia, J; Hakonarson, H. “ADHD & Pharmacotherapy: Past, Present and Future: A Review of the Changing Landscape of Drug Therapy for Attention Deficit Hyperactivity Disorder.”. Ther Innov Regul Sci 49 (5): 632-642. doi:10.1177/2168479015599811. PMC 4564067. PMID 26366330.
Malykh, AG; Sadaie, MR (12 February 2010). “Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders.”. Drugs 70 (3): 287-312. doi:10.2165/11319230-000000000-00000. PMID 20166767.

pmc.ncbi.nlm.nih.gov

“ADHD & Pharmacotherapy: Past, Present and Future: A Review of the Changing Landscape of Drug Therapy for Attention Deficit Hyperactivity Disorder”. Therapeutic Innovation & Regulatory Science 49 (5): 632–642. (September 2015). doi:10.1177/2168479015599811. PMC 4564067. PMID 26366330.
Connolly, J; Glessner, J; Kao, C; Elia, J; Hakonarson, H. “ADHD & Pharmacotherapy: Past, Present and Future: A Review of the Changing Landscape of Drug Therapy for Attention Deficit Hyperactivity Disorder.”. Ther Innov Regul Sci 49 (5): 632-642. doi:10.1177/2168479015599811. PMC 4564067. PMID 26366330.

prnewswire.com (Global: 406^th place; Japanese: 1,806^th place)

“Press Release: Medgenics, Inc. Announces Name Change to Aevi Genomic Medicine, Inc.”. Aevi via MarketWired (2016年12月16日). 2020年5月6日閲覧。

seekingalpha.com (Global: 5,344^th place; Japanese: low place)

Sharma, B.. “Medgenics: NFC-1 Could Be A Key Future Revenue Driver.”. 2020年5月6日閲覧。

springer.com (Global: 274^th place; Japanese: 596^th place)

adisinsight.springer.com

“Drug Profile Fasoracetam”. 2020年5月6日閲覧。

ファソラセタム (Japanese Wikipedia)

books.google.com (Global: 3rd place; Japanese: 61st place)

doi.org (Global: 2nd place; Japanese: 6th place)